CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 31 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $35,873 | +98.8% | 81,124 | -1.2% | 0.00% | – |
| Q4 2022 | $18,046 | -39.8% | 82,143 | 0.0% | 0.00% | – |
| Q3 2022 | $30,000 | -43.4% | 82,143 | 0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -20.9% | 82,143 | 0.0% | 0.00% | – |
| Q1 2022 | $67,000 | -29.5% | 82,143 | -1.3% | 0.00% | – |
| Q4 2021 | $95,000 | -54.8% | 83,240 | -0.7% | 0.00% | – |
| Q3 2021 | $210,000 | -9.1% | 83,842 | +7.8% | 0.00% | – |
| Q2 2021 | $231,000 | -73.1% | 77,791 | -68.2% | 0.00% | – |
| Q1 2021 | $858,000 | -38.2% | 244,590 | -16.2% | 0.00% | – |
| Q4 2020 | $1,388,000 | -5.6% | 291,918 | -3.5% | 0.00% | – |
| Q3 2020 | $1,470,000 | +172.7% | 302,425 | +82.1% | 0.00% | – |
| Q2 2020 | $539,000 | +131.3% | 166,067 | +265.1% | 0.00% | – |
| Q1 2020 | $233,000 | +15.9% | 45,484 | +3.0% | 0.00% | – |
| Q4 2019 | $201,000 | -74.3% | 44,138 | -65.5% | 0.00% | – |
| Q3 2019 | $783,000 | +163.6% | 127,785 | +162.0% | 0.00% | – |
| Q2 2019 | $297,000 | +9.6% | 48,772 | 0.0% | 0.00% | – |
| Q1 2019 | $271,000 | -11.1% | 48,772 | -9.5% | 0.00% | – |
| Q4 2018 | $305,000 | -20.6% | 53,868 | +47.1% | 0.00% | – |
| Q3 2018 | $384,000 | +49.4% | 36,610 | +57.8% | 0.00% | – |
| Q2 2018 | $257,000 | +60.6% | 23,194 | +15.8% | 0.00% | – |
| Q1 2018 | $160,000 | +3.9% | 20,035 | +6.9% | 0.00% | – |
| Q4 2017 | $154,000 | +32.8% | 18,735 | +0.0% | 0.00% | – |
| Q3 2017 | $116,000 | +2.7% | 18,733 | 0.0% | 0.00% | – |
| Q2 2017 | $113,000 | +14.1% | 18,733 | 0.0% | 0.00% | – |
| Q1 2017 | $99,000 | +2.1% | 18,733 | +31.0% | 0.00% | – |
| Q4 2016 | $97,000 | -7.6% | 14,297 | +0.7% | 0.00% | – |
| Q3 2016 | $105,000 | -9.5% | 14,202 | 0.0% | 0.00% | – |
| Q2 2016 | $116,000 | +90.2% | 14,202 | +39.2% | 0.00% | – |
| Q1 2016 | $61,000 | -76.1% | 10,200 | -78.7% | 0.00% | – |
| Q4 2015 | $255,000 | +522.0% | 47,865 | +369.3% | 0.00% | – |
| Q3 2015 | $41,000 | -28.1% | 10,200 | -37.9% | 0.00% | – |
| Q2 2014 | $57,000 | – | 16,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |